Effects of antiretrovirals on major adverse cardiovascular events in the REPRIEVE trial: a longitudinal cohort analysis

By afschroeder • June 8, 2025

Fichtenbaum CJ, Malvestutto CD, Watanabe MG, Davies Smith E, Ribaudo HJ, McCallum S, Fitch KV, Currier JS, Diggs MR, Chu SM, Aberg JA, Lu MT, Valencia J, Gómez-Ayerbe C, Brar I, Valdez Madruga J, Bloomfield GS, Douglas PS, Zanni MV, Grinspoon SK; REPRIEVE Investigators. Effects of antiretrovirals on major adverse cardiovascular events in the REPRIEVE trial: a longitudinal cohort analysis. Lancet HIV. 2025 Jun 4:S2352-3018(25)00043-8. doi: 10.1016/S2352-3018(25)00043-8. Epub ahead of print. PMID: 40482662.

Tags: Infectious Diseases, Publications

Inflammation, antiretroviral therapy continuation, and HIV disease progression in postpartum women with HIV

Shivakoti R, Giganti MJ, Lederman MM, Ketchum R, Brummel S, Moisi D, Matubu AT, Dadabhai S, Moodley D, Violari A, Chinula L, Owor M, Gupta[...]

Structure, identification and characterization of the RibD-enolase complex in Francisella

Liu X, Clemens DL, Lee BY, Aguirre R, Horwitz MA, Zhou ZH. Structure, identification and characterization of the RibD-enolase complex in Francisella. Protein Cell. 2025[...]

Cardiac Implantable Device Infection Surveillance Algorithm

Mull HJ, Golenbock SW, Basnet Thapa D, Shin MH, Harvey KL, Lamkin RP, Strymish J, Branch-Elliman W. Cardiac Implantable Device Infection Surveillance Algorithm. JAMA Netw[...]